Clinical Trial Update: Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluated beclomethasone for treating graft-versus-host disease affecting the GI tract from the esophagus to the colon.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Beclomethasone (beclomethasone)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Breast Cancer, Chronic Myeloproliferative Disorders | Phase 1, Phase 2 | Status: COMPLETED